MCK

SELL

McKesson Corporation

Healthcare · Rank #422 · Analyzed Oct 18, 2026

$1004.84

Current Price

$1224.74

Intrinsic Value

+21.9%

Upside/Downside

1/10

Score

1/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score1/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 21.9%

Fair Value Range

Low$498.52

Base (IV)$1224.74

High$1528.87

Entry Points

Conservative$348.96

Moderate$498.52

Aggressive$857.32

Quality & Moat Breakdown

Return on Equity0.0% → 0/1.0

Debt LevelD/E 100 → 0/1.0

Revenue QualityGrowth 12.5%, margin Δ-0.1% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins1.1% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.